Caranx Uses AI to Improve TAVI ProceduresCaranx Uses AI to Improve TAVI Procedures
The company has filed for FDA submission for TAVIPILOT Soft, a software that would provide real-time intra-operative guidance during TAVI procedures.
January 27, 2025
.png?width=1280&auto=webp&quality=95&format=jpg&disable=upscale)
One medtech company is combining the power of artificial intelligence with transcatheter aortic valve implantation (TAVI) procedures.
Caranx Medical said it filed for FDA submission for TAVIPILOT Soft, a software that would provide real-time intra-operative guidance for TAVI. The NICE, France-based company plans to introduce TAVIPILOT Soft by the end of the year.
“Allowing a broader number of cardiologists, surgeons and interventional cardiology centers to perform complex procedures, such as TAVI, the Caranx AI-driven software and autonomous robot is at the heart of our mission of entrepreneurs and business builders to save lives and revolutionize medicine” says Philippe Pouletty, MD, founder of Caranx and CEO of Truffle Capital.
TAVIPILOT Soft tracks real-time anatomical and instrument landmarks. It enables precise and accurate heart valve positioning and delivery. The company said TAVIPILOT Soft is expected to be a revolution for the transcatheter replacement of aortic valves, which is limited today because it is reserved for the most experienced cardiologists and centers. Caranax noted TAVIPILOT Soft is compatible with all cardiac Imaging Systems and will be compatible with principal TAVI heart valves on the market.
The TAVI space has become more competitive since the first procedure was performed 20 years ago. Most recently, Edwards Lifesciences announced one of the biggest acquisitions in the space. Irvine, CA-based company said it would acquire JenaValve.
Edwards also acquired JC Medical, which is the maker of the J-Valve System.
About the Author
You May Also Like